At A Glance
Healthcare marketing now runs across mixed-identity conditions, where authenticated data, contextual signals, and aggregated measurement all show up in the same campaign. Pharma brands need infrastructure that keeps DTC and HCP identity separate and still connects fragmented signals across activation, privacy, and measurement. Experian acts as an independent, privacy-first identity, data, and workflow layer for pharma marketers, designed specifically for this operating environment.Originally published in Digiday
Key takeaways
- Pharma campaigns now span environments with very different identity conditions, from strong addressability to contextual only signals, which makes coordination a core infrastructure challenge.
- Privacy and compliance rules require DTC (patient) and HCP (healthcare professional) data to stay in separate, non-overlapping workflows at every stage.
- Experian’s identity and workflow layer governs DTC tokenized matching and HCP deterministic National Provider Identifier (NPI) resolution as two distinct processes, never one merged identity path.
- Partner-enabled measurement connects exposure data to outcomes like script lift and qualified HCP engagement through trusted partners including IQVIA Digital, PurpleLab, and OptimizeRx.
A pharmaceutical brand launching a campaign today might rely on authenticated data in one environment, contextual signals in another, and aggregated measurement somewhere else entirely. That’s the reality of healthcare marketing right now, and most brands are still building the operational model to match it.
In a mixed-identity ecosystem, performance comes from the ability to coordinate multiple signal types across activation, privacy, and measurement workflows. Accuracy and scale depend on knowing which approach fits which environment and having the infrastructure to execute across all of them.
From onboarding to outcomes
Pharma marketing teams need identity workflows that can support accurate audience creation, governed activation, and partner-enabled measurement without combining DTC and HCP identity paths.
Download our pharma marketing playbook to help your team:
- Plan DTC and HCP identity strategies with clearer separation
- Prepare audiences for activation across approved channels and partners
- Evaluate audience quality, usable reach, and governance
Healthcare campaigns run across different signal conditions
Healthcare campaigns now run across environments with very different identity conditions, from fully addressable channels to contextual only placements. Digital advertising has long assumed that better identity leads to better targeting, frequency management, orchestration, and measurement, but healthcare has always operated with more constraints than most categories. Those constraints are becoming impossible to ignore as budgets move into connected TV (CTV), point-of-care, publisher-direct, programmatic and retail media-adjacent environments.
That shift changes the operating model. Marketers now have to manage audience strategy, supply quality and performance across channels that don’t support the same level of addressability, interoperability, or measurement visibility. In some environments, identity is strong and can support targeting and measurement. In others, identity is limited or unavailable, and marketers have to rely on contextual or aggregated signals. Managing across both environments is now a core infrastructure challenge for healthcare marketers, and it’s one that requires a deliberate strategy rather than a channel-by-channel patch.
Privacy risk is a media infrastructure issue
Privacy risk in healthcare marketing now shapes how campaigns get built and run from the ground up, extending well beyond compliance into media infrastructure itself. Tighter privacy and compliance expectations mean audience construction, exposure management, and outcomes analysis all get more complex once tracking is restricted.
Data can’t move freely across partners or workflows, and DTC and HCP data environments need to stay isolated from one another. This is especially true in pharma, where the stakes of a compliance misstep extend well beyond a campaign. This creates a more demanding operating model. Healthcare marketers have to balance identity-based and privacy-forward approaches while maintaining reach, relevance, and accountability. That balance requires governance that’s built into the infrastructure, not layered on top of it after the fact.
Experian acts as an independent, privacy-first identity, data, and workflow layer for pharma marketers, designed specifically for this operating environment:
These workflows are governed separately by design, with governed onboarding connecting fragmented DTC and HCP signals to activation-ready audiences without collapsing the two identity paths.
The mixed-identity playbook starts with matching the approach to the environment
The right mixed-identity approach depends on what each environment can support and what the campaign is needs to achieve. A pharmaceutical team may want more addressability, a publisher may only offer contextual or cohort signals, and a measurement partner may need exposure data, while platforms limit how identifiers can be shared.
Healthcare marketers need an operating model built for multiple identity conditions, with clear rules for how signals can be connected, activated, and measured without increasing privacy or compliance risk. That may include:
Experian’s infrastructure supports all three modes:
The missing layer in pharma marketing. Watch our Q&A
Supply quality is a prerequisite for measurement
Supply quality determines whether measurement in a mixed-identity environment can be trusted. When tracking and addressability vary across channels, advertisers need confidence that impressions ran in the right environments and under the right conditions before they can trust any downstream outcomes.
This is especially true in CTV and programmatic, where campaigns span fragmented supply paths, publishers, devices, and partners. Outcomes like script lift or provider engagement are only meaningful if the underlying exposure is reliable and well understood. In healthcare, this also ties directly to brand suitability and disclosure control. Curated supply, publisher-direct deals and placement-level transparency help campaigns run in appropriate environments and give measurement a more defensible foundation.
Clean rooms and tokenization support this, but their effectiveness depends on governance, interoperability, and whether insights can move cleanly across partners and workflows. Partner-enabled measurement, connecting exposure data to outcomes through trusted partners including IQVIA Digital, PurpleLab, and OptimizeRx, is structured in two steps:
- Link activation and measurement IDs without collapsing them into an open identity environment
- Produce aggregated, defensible outcomes including script lift, qualified HCP engagement, and verified delivery
Mixed-identity is the operating reality, and infrastructure is how you manage it
Mixed-identity is now the operating reality for healthcare marketing, not a temporary phase to work around. Performance depends on working across environments where identity is sometimes strong and sometimes limited by design. Healthcare marketers don’t need to pick a single identity approach and apply it everywhere. Building infrastructure that connects deterministic identity, tokenized matching, and contextual signals, keeping compliance, operational flexibility, and trust intact at every step, is what separates the brands managing this well from the ones still patching it channel by channel.
Talk to our team about your healthcare identity strategy
Whether you’re running DTC, HCP, or both, our team can help you build an infrastructure that works across identity environments. Let’s connect.
About the author
Kevin Dunn
Chief Revenue Officer, Experian
Kevin Dunn joins Experian Marketing Services with more than 20 years of leadership experience across marketing and advertising technology, most recently serving as Senior Vice President of Brands and Agencies at LiveRamp. In that role, he led growth across retail, CPG, travel, hospitality, financial services, and healthcare, overseeing new business, account expansion, and channel partnerships.
Kevin is known for building cohesive, accountable teams and leading with optimism, clarity, and a strong sense of shared purpose. His leadership philosophy centers on empowering people, driving positive outcomes for clients and fostering a culture where teams can grow, take smart risks, and succeed together.
FAQs
Mixed-identity means a healthcare campaign relies on more than one type of signal at once, such as authenticated data in one channel, contextual data in another, and aggregated measurement in a third. Pharma brands increasingly need infrastructure that coordinates all of these signal types together instead of treating each channel as a separate problem.
Experian keeps DTC and HCP identity in distinct, non-overlapping workflows so patient data and healthcare professional data never combine. DTC activation runs on high-fidelity tokenized matching, and HCP activation relies on deterministic National Provider Identifier (NPI) resolution using verified attributes like specialty and practice location.
Supply quality matters because outcomes like script lift or provider engagement only mean something if the underlying ad exposure is reliable. Curated supply, publisher-direct deals, and placement-level transparency give healthcare marketers a more defensible foundation before they trust any downstream measurement result.
Partner-enabled measurement connects exposure data to outcomes through trusted third parties such as IQVIA Digital, PurpleLab, and OptimizeRx, without merging activation and measurement identifiers into one open identity environment. The result is aggregated, defensible outcomes like script lift, qualified HCP engagement, and verified delivery.
Healthcare marketers don’t have to choose one approach over the other, since most campaigns already run across both conditions at the same time. Building infrastructure that connects deterministic identity, tokenized matching, and contextual signals is what allows a campaign to stay compliant while still reaching the right audience.
Latest posts
Five Norwegian startups selected to establish U.S. presence NEW YORK, Aug. 15, 2016 /PRNewswire/ — Tapad, the leader in cross-device marketing technology and now a part of Experian, has announced its new entrepreneurial mentorship initiative, the Propeller Program. Five early-stage startups from Norway have been chosen by Are Traasdahl, native of Norway and Tapad’s CEO and founder. The selected companies will share Tapad’s New York City workspace, receive C-level guidance and help establish a U.S. presence. The following companies have been selected to participate in the inaugural Propeller Program – a 12-month program beginning September 19, 2016: Bubbly – Developers of a platform that enables in-store customer feedback with dashboards and tools that facilitate real-time store response BylineMe – A marketplace for freelancers, publishers and brands to connect for content creation and distribution services Eventum – A property-sharing group that digitally assists in securing venues for meetings and corporate events Xeneta – A database that organizes the best contracted freight rates in real time and on demand “We are supporting startups that we feel represent the future of service offerings,” said Traasdahl. “It is with incredible pride that we invite these entrepreneurial teams from Norway to join us in New York Citythis year. Mentorship opportunities for early-stage companies are so important, particularly for those based outside the U.S. I look forward to giving the Propeller Program participants access to the expertise of my seasoned team and to our wide network of resources. Hopefully, it will be a game-changing year for many of them.” Contact us today
As partnership deals mount, aggressive hiring underway for unified cross-screen technology leaders NEW YORK, July 19, 2016 /PRNewswire/ — Tapad, the leader in cross-device marketing technology and now a part of Experian, has announced plans for aggressive expansion in the Asia Pacific (APAC) region. This move capitalizes on Tapad’s exceptional performance for brands and marketing technology companies in North America and Europe. With it’s proprietary Tapad Device Graph™, the company will enable global, regional and local clients and partners to understand, monetize and measure marketing to users across screens. The Tapad Device Graph is recognized as the most accurate, scalable cross-screen solution in the market today. The decision to expand into APAC was based on increased demand from global, as well as local, brands and clients, many of which have a strong market presence throughout the region. In addition to expanding its roster of world-class data partners, plans include building a world-class team in Singapore. Over the next few months, Tapad APAC will also establish local entities in additional markets. To accelerate its ramp-up, Tapad APAC is actively recruiting in many areas, ranging from skilled and experienced solutions engineers to seasoned sales and marketing professionals. “Tapad is thrilled to be answering the call for cross-device excellence in APAC,” said Pierre Martensson, GM of Tapad APAC. “Our Device Graph is adding millions of devices daily and achieves unmatched levels of scale and accuracy while protecting consumer privacy. This meets a critical need in the region.” Tapad appointed Martensson as General Manager of Tapad APAC in May, kicking off expansion in the region. Martensson comes to Tapad with nearly a decade of operations experience throughout APAC, having transformed, developed and grown global organizations. To learn more about partnership and employment opportunities available with Tapad in APAC, visit www.experian.com/careers. Contact us today
Combined technology gives marketers an enhanced view of the customer for improved planning, targeting and optimization NEW YORK, July 12, 2016/PR Newswire/ – Tapad, the leader in cross-device marketing technology and now a part of Experian, today announced a partnership with Conversion Logic, the martech industry’s most accurate unified marketing attribution provider. Conversion Logic will incorporate unified cross-screen data from Tapad’s Device Graph™ to identify related devices and media exposures to enhance reporting on the path to conversion. By connecting Conversion Logic’s proprietary Ensemble Method, which combines numerous state-of-the-art machine learning algorithms, tuned for each customer use-case for the most accurate results, with Tapad’s unified, cross-device technology, marketers will benefit from a highly scientific approach to assessing advertising effectiveness with full, comprehensive customer insights. Linking these technologies will increase marketers’ real-time ability to optimize brands’ marketing channel spend and creative at a more granular level. During the past six months, Tapad has rapidly grown its data business, doubling the number of companies integrating the Device Graph™ into their platforms and growing the annualized revenue run rate by 210%. Tapad’s highly scalable, cross-device data has been confirmed by Nielsen to be very precise. Tapad augments platforms’ and publishers’ tech stacks with additional scale and relevancy, granting advertisers amplified targeting and analysis options. The growth of the Device GraphTM has allowed Tapad to provide a growing network that benefits all partners with more efficient, effective consumer engagement. “Combining highly accurate data from Tapad with our own user ID technology and understanding how devices may be related at an individual level provides additional visibility into the path to conversion,” said Alison Lohse, COO and co-founder of Conversion Logic. “The more we know about the customer journey, the more effective, efficient and customized marketers can be with marketing efforts. With Tapad, we have achieved a unified customer view that helps us piece together the purchase journey while preserving proven accuracy.” “Conversion Logic’s Ensemble Method delivers singularly customized and precise results that are not just accurate, but actionable,” said Dave Fall, COO of Tapad. “The combination of powerful technology and a user-friendly interface, plus Tapad’s ability to only consider relevant and scalable components in the marketplace, creates a more concentrated and beneficial environment for both its partners and clients.” Contact us today